Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age22+
SponsorRigicon, Inc.

About this trial

This study evaluates the long-term safety and effectiveness of the Rigicon Infla10® Inflatable Penile Prosthesis in patients with erectile dysfunction. The study follows patients implanted with the Rigicon Infla10® Pulse™ Dynamic Inflatable Penile Prosthesis for up to 3 years after implantation.

Eligibility criteria

Qualifiers

Male ≥22 years of age.

Diagnosed with erectile dysfunction (impotence).

Agree to receive Infla10® three-piece IPP as an ED treatment.

Willing to complete all protocol required for follow-up visits and tests.

Disqualifiers

Contraindication to general anesthesia.

Known allergy or sensitivity to product materials as indicated in the device labeling.

Previous penile prosthesis or prior enlargement surgeries

Diagnosed penile sensory neuropathy.

Trial design

Treatments tested in this trial

  • Rigicon Infla10® Inflatable Penile Prosthesis (IPP)

Treatment groups

182 Participants
are divided into 1 treatment group

Locations

7
Florida
Perito Urology33146, Coral Gables United States
Georgia
Atlanta Cosmetic Urology30305, Atlanta United States
Illinois
UroPartners60612, Chicago United States
Massachusetts
Kramer Urology02601, Hyannis United States

Sponsors and collaborators

Rigicon, Inc.

Lead sponsor